Literature DB >> 6167587

Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase.

K Yang, H Samanta, J Dougherty, B Jayaram, R Broeze, P Lengyel.   

Abstract

(2'-5')(A)n synthetase is one of the mediators of interferon action. If activated by double-stranded RNA it converts ATP into pyrophosphate and (2'-5')(A)n. In turn, (2'-5')(A)n activates a latent endoribonuclease (RNase L) which cleaves single-stranded RNA. We report here the isolation and characterization of a homogeneous human (2'-5')(A)n synthetase. The enzyme was purified from interferon-treated HeLA S3 cells by chromatography of a ribosomal salt wash fraction on DEAE-cellulose, poly(I) . poly(C) agarose, and CM-cellulose. The purified (2'-5')(A)n synthetase can convert over 90% of ATP into (2'-5')(A)n. The enzyme is unstable but can be stabilized by certain nonionic detergents (e.g. Triton X-100). Its apparent Mr = 100,000, as determined by gel electrophoresis in sodium dodecyl sulfate, and about 80,000, as determined by centrifugation through a glycerol gradient. The human (2'-5')(A)n synthetase is similar to the corresponding enzyme from mouse Ehrlich ascites tumor cells, but differs from the latter in size (100,000 versus 105,000 daltons) and in ionic conditions required for maximal activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167587

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Regulation of 2',5'-oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor.

Authors:  M A Garcia-Blanco; P Lengyel; E Morrison; C Brownlee; C D Stiles; M Rutherford; G Hannigan; B R Williams
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  3' end structure of the human (2'-5') oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression.

Authors:  P Benech; G Merlin; M Revel; J Chebath
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

3.  Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.

Authors:  V Bonnevie-Nielsen; I Heron; T P Monath; C H Calisher
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells.

Authors:  G Merlin; J Chebath; P Benech; R Metz; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  The murine 2-5A synthetase locus: three distinct transcripts from two linked genes.

Authors:  M N Rutherford; A Kumar; A Nissim; J Chebath; B R Williams
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

6.  Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies.

Authors:  A G Hovanessian; A G Laurent; J Chebath; J Galabru; N Robert; J Svab
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

7.  Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.

Authors:  P Benech; Y Mory; M Revel; J Chebath
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

8.  Human 2'-phosphodiesterase localizes to the mitochondrial matrix with a putative function in mitochondrial RNA turnover.

Authors:  Jesper Buchhave Poulsen; Kasper Røjkjær Andersen; Karina Hansen Kjær; Fiona Durand; Pierre Faou; Anna Lindeløv Vestergaard; Gert Hoy Talbo; Nick Hoogenraad; Ditlev Egeskov Brodersen; Just Justesen; Pia Møller Martensen
Journal:  Nucleic Acids Res       Date:  2011-01-17       Impact factor: 16.971

9.  Nucleic Acid Immunity.

Authors:  G Hartmann
Journal:  Adv Immunol       Date:  2016-12-15       Impact factor: 3.543

Review 10.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.